Expired Canadian patentCanada
Use of a fibrate and orlistat for the treatment of obesity
CA 2518205 C · Owner: Edgar, Alan · Inventors: Edgar, Alan
Overview
Drawings and full text
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention relates to the use of a fibrate and orlistat to treat patients suffering from obesity.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed March 12, 2004 and granted May 8, 2012. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended March 12, 2024.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by March 12, 2026.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledMarch 12, 2004
GrantedMay 8, 2012
Term endedMarch 12, 2024
Patent numberCA 2518205 C
Classification (IPC)A61K31/19 +2 more
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.